{"id":969308,"date":"2026-06-02T05:33:05","date_gmt":"2026-06-02T09:33:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/"},"modified":"2026-06-02T05:33:05","modified_gmt":"2026-06-02T09:33:05","slug":"propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/","title":{"rendered":"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain"},"content":{"rendered":"<h2>\nDr. Juan Carlos Izpis\u00faa Provides the UGR With the Keys to Science Against Ageing<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>MELBOURNE, Australia, June  02, 2026  (GLOBE NEWSWIRE) &#8212; Propanc Biopharma, Inc. (Nasdaq: PPCB) (\u201cPropanc\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced that Mr. James Nathanielsz, Propanc\u2019s Chief Executive Officer, attended a keynote address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d the title of a new edition of &#8216;Dialogues with Society&#8217;, an event organized by the Social Council of the University of Granada (UGR), held at the historical Hospital Real, Granada, Spain, first inaugurated in 1526. Dr. Juan Carlos Izpis\u00faa provided the UGR with the keys to science against ageing. Dr. Izpis\u00faa is one of the world&#8217;s foremost influential scientists in the field of developmental biology and regenerative medicine.<\/p>\n<p>The prestigious international researcher Dr. Izpis\u00faa helped to understand the cellular and molecular mechanisms responsible for embryonic development, from the moment of fertilization to the formation of an adult organism composed of millions of cells. These discoveries are having a significant impact on the development of novel treatments for diseases and have contributed to the creation of new frontiers for biomedical science, in fields such as organ and tissue regeneration and the fight against human ageing. The Rector of the UGR, Pedro Mercado, and the President of the Social Council, Teresa Pag\u00e9s, participated in this meeting. Juan Antonio Marchal Corrales, Professor of Human Anatomy and Embryology at the University of Granada, presented the conference.<\/p>\n<p>\u201cIt was an honor to attend the keynote address of Dr. Izpis\u00faa whose scientific interests and vision for the future of humanity are world renowned,\u201d said Mr. Nathanielsz. \u201cPropanc\u2019s research into the use of proenzymes to differentiate specific target cells at the core of many age-related diseases is right in the center of this pioneering field of research. Our collaboration with the Universities of Granada and Ja\u00e9n will continue to investigate this field of research, specifically cell rejuvenation of tissues relating to diseases such as fibrosis and diabetes, as well as cancer from solid tumors. Given our lead asset, PRP, is on schedule to enter a Phase 1b, First-In-Human study in advanced cancer patients, we are poised to transform this key research into potentially meaningful clinical benefits that could unlock the mystery of many different chronic diseases.\u201d<\/p>\n<p>Dr. Izpis\u00faa belongs to Altos Labs, San Diego Institute of Science (USA), and holds an honorary doctorate from the UGR. The scientist held a meeting prior to the event with the Rector of the University of Granada, Pedro Mercado, in which the vice-rector for the Ceuta and Melilla Campuses, Strategic Planning and Communication, Salvador del Barrio, and the President of the Social Council, Teresa Pag\u00e9s, among other personalities, also participated. Mr. Nathanielsz was an honorary guest of Professor Marchal Corrales and Macarena Per\u00e1n, Professor of Human Anatomy and Embryology, at the University of Ja\u00e9n, and Propanc\u2019s lead coresearchers.<\/p>\n<p align=\"center\">\n        \n      <\/p>\n<p align=\"center\">Left to Right: Professor Marchal Corrales, Dr. Juan Carlos Izpis\u00faa, Professor Macarena Per\u00e1n &amp; Mr. James Nathanielsz<\/p>\n<p align=\"center\">\n        \n      <\/p>\n<p align=\"center\">Dr. Juan Carlos Izpis\u00faa (center), UGR Dignitaries &amp; Mr. James Nathanielsz<\/p>\n<p>For the original article relating to this event, please access the following link:<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DZn4tfLH5fSVYAn7Vj2tM6jnGuf-4mZv8dtAy6jz7tLv00zYxJs6Yn64Xnr8K5l52_RgXyO2pkgl8OWHgfR8NAbznwqAGRQnGHP-n31NcaL9oXFs9FLpprg9c37BrBYFmfMfMMOZda7K-YYKuN1QwAM7bp7OBgj0_043uqxfR5vOdEjuAe3jANsOgbI2QUYLbowir7LOebHSbakd_aimAv4IFn8Pm9jEwdkAb3YTbdvqvjdks3jSMldxt0C41IICNOWGTkNf-AUNXg476QynkQKBpPNfwRqeva7mmiy6BztbO7q5BQbiYOwicHSRjlFS\" rel=\"nofollow\" target=\"_blank\">Juan Carlos Izpis\u00faa provides the UGR with the keys to science against ageing &#8211; Canal UGR<\/a>\n      <\/p>\n<p>\n        <strong>About Propanc Biopharma, Inc.<\/strong>\n      <\/p>\n<p>Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The Company\u2019s lead product candidate, PRP, is designed to address the underlying drivers of cancer proliferation and spread.<\/p>\n<p>\n        <strong>More information:<\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7xrXNAvSoAY3NS_yGuC9es4lE0xhvlw5g2y7js6kBx6xIb1w8yNDnf7YAa_JoiQWn6cwfQh7XMQDRzBMmsy6OUz9j3gNXszhDdcuWEjdBqU=\" rel=\"nofollow\" target=\"_blank\">www.propanc.com<\/a>\n      <\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p>All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company\u2019s expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors, made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are not historical facts but rather are based on the Company\u2019s current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as \u201cmay,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cshould,\u201d \u201canticipate,\u201d \u201cpredict,\u201d \u201cpotential,\u201d \u201ccontinue,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company\u2019s control. Forward-looking statements are not guarantees of future actions or performance. Actual results may differ materially from those in the forward-looking statements because of several factors, including, without limitation, risks and uncertainties related to market conditions, as well as those risks described under \u201cRisk Factors\u201d in the prospectus related to the proposed offering and those described in the Company\u2019s filings with the SEC. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.<\/p>\n<p>\n        <strong>Company:<\/strong><br \/>\n        <br \/>Propanc Biopharma, Inc.<br \/>James Nathanielsz<\/p>\n<p>+61-3-9882-0780<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=C28QiX_D9-2Yzu3xJ1uBGRKj22azivuRwAj9UklXn_nMehTZQado2Iaz3pB_ZkjF4h2Pqw5AVT2f3UT4Ja-DgdsOtuudnoHfmqBG5JkV1eQ=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <u>info@propanc.com<\/u><br \/>\n        <\/a>\n      <\/p>\n<p>\n        <strong>Investor Contact:<\/strong>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PbfqF0Uwd9OOEz-9Zb74jrBA3OraV-CP4B6k_abIdI-3la3WBaUVwQj8M_6pNBlW_1xWwtLBmkHi-CbKElEbJeProox_zEbUDvBxzBCoVGw=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <u>irteam@propanc.com<\/u><br \/>\n        <\/a>\n      <\/p>\n<p>Photos accompanying this announcement are available at\u00a0<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ugkP7yVcF54ofoiO7upPQuUv4KYhJV7fMivA6387y7lxAS3gyunbuMaJur9xzX7sH4fIjf8XD_8H4VfDAnswITAQo6hHPVP6jc2uED6ghFWYtgE-IGJBHXIRXq6OltN1whS2FU_6aPudyTI91cqMPdbVJ0c5PLTyagL5NOBkb4EsPSdBBx74HvQvM3cRB4sBLXd0IA1N6RX7VAIaXRdtAK0iGcfnuTzMiDDBPJqTgErmoMr4SajfLuLhuVljjR_HIB3Bfn-kjJbUapJXQp5wwg==\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/efc2b36e-68f2-4988-b67b-58ddcd013f55<\/a>\n      <\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ugkP7yVcF54ofoiO7upPQuUv4KYhJV7fMivA6387y7lxAS3gyunbuMaJur9xzX7syULVR9kA3WweE6VyEajgf_IGNWguRQT59qa6F5jQuE4iFKrrx4b3BTdt2VH9rlsp1dA0b9wd8K9JfIPpvcjbJGqjVzpZ-FGurh66xfs8BzF4qa_YT6fm0mB9Rq4CC1ZjEPiKYnNJDeoGgKLEQbizHCbG4teVpNr0xhv9jG2ABbHC30cxHQKLiMbZ58JI2CW1-Yeon2G7ffb8erWtbgVSzA==\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/60f1b3c0-7f71-48ef-855a-8c4c45f37129<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGJkNzdlOWYtZjQ5ZS00MTgyLTg3ZTYtMTdmYzYwOTkxY2U3LTEzMDI2NjItMjAyNi0wNi0wMi1lbg==\/tiny\/Propanc-Biopharma-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Juan Carlos Izpis\u00faa Provides the UGR With the Keys to Science Against Ageing MELBOURNE, Australia, June 02, 2026 (GLOBE NEWSWIRE) &#8212; Propanc Biopharma, Inc. (Nasdaq: PPCB) (\u201cPropanc\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced that Mr. James Nathanielsz, Propanc\u2019s Chief Executive Officer, attended a keynote address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d the title of a new edition of &#8216;Dialogues with Society&#8217;, an event organized by the Social Council of the University of Granada (UGR), held at the historical Hospital Real, Granada, Spain, first inaugurated in 1526. Dr. Juan Carlos Izpis\u00faa provided the UGR with the keys to science against ageing. Dr. Izpis\u00faa &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-969308","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dr. Juan Carlos Izpis\u00faa Provides the UGR With the Keys to Science Against Ageing MELBOURNE, Australia, June 02, 2026 (GLOBE NEWSWIRE) &#8212; Propanc Biopharma, Inc. (Nasdaq: PPCB) (\u201cPropanc\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced that Mr. James Nathanielsz, Propanc\u2019s Chief Executive Officer, attended a keynote address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d the title of a new edition of &#8216;Dialogues with Society&#8217;, an event organized by the Social Council of the University of Granada (UGR), held at the historical Hospital Real, Granada, Spain, first inaugurated in 1526. Dr. Juan Carlos Izpis\u00faa provided the UGR with the keys to science against ageing. Dr. Izpis\u00faa &hellip; Continue reading &quot;Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-02T09:33:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain\",\"datePublished\":\"2026-06-02T09:33:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/\"},\"wordCount\":962,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/\",\"name\":\"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=\",\"datePublished\":\"2026-06-02T09:33:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/","og_locale":"en_US","og_type":"article","og_title":"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain - Market Newsdesk","og_description":"Dr. Juan Carlos Izpis\u00faa Provides the UGR With the Keys to Science Against Ageing MELBOURNE, Australia, June 02, 2026 (GLOBE NEWSWIRE) &#8212; Propanc Biopharma, Inc. (Nasdaq: PPCB) (\u201cPropanc\u201d or the \u201cCompany\u201d), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced that Mr. James Nathanielsz, Propanc\u2019s Chief Executive Officer, attended a keynote address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d the title of a new edition of &#8216;Dialogues with Society&#8217;, an event organized by the Social Council of the University of Granada (UGR), held at the historical Hospital Real, Granada, Spain, first inaugurated in 1526. Dr. Juan Carlos Izpis\u00faa provided the UGR with the keys to science against ageing. Dr. Izpis\u00faa &hellip; Continue reading \"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-02T09:33:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain","datePublished":"2026-06-02T09:33:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/"},"wordCount":962,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/","name":"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=","datePublished":"2026-06-02T09:33:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTMwNCM3NjI5MjY5IzIyOTExMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/propanc-biopharmas-ceo-attends-keynote-address-rejuvenation-and-health-science-for-an-ageing-society-at-the-university-of-granada-spain\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Propanc Biopharma\u2019s CEO Attends Keynote Address, \u201cRejuvenation and Health: Science for an Ageing Society,\u201d at the University of Granada, Spain"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=969308"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969308\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=969308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=969308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=969308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}